CMTA Legacy Society

Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.


  • CMT2E Gene Therapy Project ApprovedCMT2E Gene Therapy Project Approved
    The CMTA Board of Directors approved a $265,000 research project for CMT2E that aims to advance CMT2E gene therapy by demonstrating positive results for axonal forms of CMT affecting motor neurons.
    Read more ...
  • The 2020 Spring CMTA ReportThe 2020 Spring CMTA Report
    In a world turned upside down, The CMTA Report continues to bring you help for today and hope for tomorrow. In this issue you’ll find helpful stories on tendon transfers, HNPP and nerve conduction studies, as well as hopeful news ...
    Read more ...
  • CMTA Board Approves CMT1B ProjectCMTA Board Approves CMT1B Project
    The CMTA Board of Directors approved a new research project aimed at developing biomarkers for CMT1B to aid in the collection of natural history data critical to clinical trials.
    Read more ...
  • Coronavirus (COVID-19) and CMTCoronavirus (COVID-19) and CMT
    The CMTA is aware that the coronavirus (COVID-19) may have more of an impact on people and families who are at higher risk of infection, so we are reaching out to share resources and ensure you are informed.
    Read more ...
  • CMTA Event Schedule Update from CEO Amy GrayCMTA Event Schedule Update from CEO Amy Gray
    The CMTA has decided to postpone and/or reschedule all upcoming CMTA branch meetings, events and walks originally scheduled to occur in March through May of 2020.
    Read more ...